Treatment of Cerebral Arteriovenous Malformations With SQUID™ Liquid Embolic Agent
Learn more about:
Related Clinical Trial
Clinical Trial for the Validation of AR Based Neuronavigation System
Impact of CErebral Endovascular PROcedures on the Systemic Immune responSe Response
Non-adhesive Liquid Embolic System in the Embolization of Cerebral Arteriovenous Malformations
Pediatric and Adult Cerebral Arteriovenous Malformation Neurofunctional Outcomes
Registry of Multimodality Treatment for Brain Arteriovenous Malformation in China
Safety and Feasibility of the Infinity Catheter for Radial Access
MRI for the Early Evaluation of Acute Intracerebral Hemorrhage
Comparison of Imaging Quality Between Spectral Photon Counting Computed Tomography (SPCCT) and Dual Energy Computed Tomography (DECT)
Lovastatin for Treatment of Brain Arteriovenous Malformations
Multimodal Imaging Techniques in Assessing the Surgical Risk for Eloquent Arteriovenous Malformations
Protocol for Staged Stereotactic Radiosurgery for Large Arteriovenous Malformations
PHIL® Embolic System Pediatric IDE
NIRS Monitoring During Intracranial Interventions
Evaluation of Nidus Occlusion After Gamma Knife Radiosurgery of Cerebral Arteriovenous Malformations Using Magnetic Resonance Imaging
ONYX Evaluation in the Endovascular Treatment of Cerebral Arteriovenous Malformations (cAVM)
Treatment of Cerebral Arteriovenous Malformations With SQUID™ Liquid Embolic Agent
Treatment of Cerebral Arteriovenous Malformations With SQUID Liquid Embolic Agent (CHOICE)
Surgical Management of Cerebral Arteriovenous Malformations Within Hybrid Operation Room
Biology of Cerebral Arteriovenous Malformations and Prognosis of Cerebral Arteriovenous Malformations
Nationwide Treatment Survey of Intracranial Arteriovenous Malformation in China
Functional Magnetic Resonance Imagine(fMRI)Navigation in Intracranial Arteriovenous Malformation Surgery